位置:首页 > 蛋白库 > RPC3_HUMAN
RPC3_HUMAN
ID   RPC3_HUMAN              Reviewed;         534 AA.
AC   Q9BUI4; O15317; Q9Y3R6;
DT   05-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   03-AUG-2022, entry version 163.
DE   RecName: Full=DNA-directed RNA polymerase III subunit RPC3;
DE            Short=RNA polymerase III subunit C3;
DE   AltName: Full=DNA-directed RNA polymerase III subunit C;
DE   AltName: Full=RNA polymerase III 62 kDa subunit;
DE            Short=RPC62;
GN   Name=POLR3C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH POLR3G AND POLR3F, AND VARIANT
RP   ARG-243.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=9171375; DOI=10.1101/gad.11.10.1315;
RA   Wang Z., Roeder R.G.;
RT   "Three human RNA polymerase III-specific subunits form a subcomplex with a
RT   selective function in specific transcription initiation.";
RL   Genes Dev. 11:1315-1326(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND IDENTIFICATION AS ANTIGEN IN SYSTEMIC
RP   SCLEROSIS.
RX   PubMed=12384934; DOI=10.1002/art.10521;
RA   Kuwana M., Kimura K., Kawakami Y.;
RT   "Identification of an immunodominant epitope on RNA polymerase III
RT   recognized by systemic sclerosis sera: application to enzyme-linked
RT   immunosorbent assay.";
RL   Arthritis Rheum. 46:2742-2747(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Totaro A.;
RT   "Genomic structure of human RNA polymerase III subunit (RPC62).";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH GTF3C4.
RX   PubMed=10523658; DOI=10.1128/mcb.19.11.7697;
RA   Hsieh Y.-J., Kundu T.K., Wang Z., Kovelman R., Roeder R.G.;
RT   "The TFIIIC90 subunit of TFIIIC interacts with multiple components of the
RT   RNA polymerase III machinery and contains a histone-specific
RT   acetyltransferase activity.";
RL   Mol. Cell. Biol. 19:7697-7704(1999).
RN   [6]
RP   IDENTIFICATION IN THE RNA POL III COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=12391170; DOI=10.1128/mcb.22.22.8044-8055.2002;
RA   Hu P., Wu S., Sun Y., Yuan C.-C., Kobayashi R., Myers M.P., Hernandez N.;
RT   "Characterization of human RNA polymerase III identifies orthologues for
RT   Saccharomyces cerevisiae RNA polymerase III subunits.";
RL   Mol. Cell. Biol. 22:8044-8055(2002).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-194, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   FUNCTION.
RX   PubMed=19631370; DOI=10.1016/j.cell.2009.06.015;
RA   Chiu Y.-H., Macmillan J.B., Chen Z.J.;
RT   "RNA polymerase III detects cytosolic DNA and induces type I interferons
RT   through the RIG-I pathway.";
RL   Cell 138:576-591(2009).
RN   [9]
RP   FUNCTION.
RX   PubMed=19609254; DOI=10.1038/ni.1779;
RA   Ablasser A., Bauernfeind F., Hartmann G., Latz E., Fitzgerald K.A.,
RA   Hornung V.;
RT   "RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA
RT   polymerase III-transcribed RNA intermediate.";
RL   Nat. Immunol. 10:1065-1072(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   INTERACTION WITH POLR3G AND POLR3GL.
RX   PubMed=24107381; DOI=10.1101/gr.161570.113;
RA   Renaud M., Praz V., Vieu E., Florens L., Washburn M.P., l'Hote P.,
RA   Hernandez N.;
RT   "Gene duplication and neofunctionalization: POLR3G and POLR3GL.";
RL   Genome Res. 24:37-51(2014).
RN   [13] {ECO:0007744|PDB:2XUB, ECO:0007744|PDB:2XV4}
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS), FUNCTION, INTERACTION WITH POLR3F;
RP   POLR3G AND POLR3GL, AND MUTAGENESIS OF 51-LYS-LYS-52; LEU-312; ARG-357;
RP   364-ARG--ARG-367; LYS-389; 445-ASN--ARG-449 AND 466-ARG--ILE-470.
RX   PubMed=21358628; DOI=10.1038/nsmb.1996;
RA   Lefevre S., Dumay-Odelot H., El-Ayoubi L., Budd A., Legrand P., Pinaud N.,
RA   Teichmann M., Fribourg S.;
RT   "Structure-function analysis of hRPC62 provides insights into RNA
RT   polymerase III transcription initiation.";
RL   Nat. Struct. Mol. Biol. 18:352-358(2011).
RN   [14] {ECO:0007744|PDB:5AFQ}
RP   X-RAY CRYSTALLOGRAPHY (7.00 ANGSTROMS) IN COMPLEX WITH POLR3GL.
RX   PubMed=26394183; DOI=10.1016/j.jsb.2015.09.004;
RA   Boissier F., Dumay-Odelot H., Teichmann M., Fribourg S.;
RT   "Structural analysis of human RPC32beta-RPC62 complex.";
RL   J. Struct. Biol. 192:313-319(2015).
CC   -!- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of
CC       DNA into RNA using the four ribonucleoside triphosphates as substrates.
CC       Specific core component of RNA polymerase III which synthesizes small
CC       RNAs, such as 5S rRNA and tRNAs. May direct with other members of the
CC       subcomplex RNA Pol III binding to the TFIIIB-DNA complex via the
CC       interactions between TFIIIB and POLR3F. May be involved either in the
CC       recruitment and stabilization of the subcomplex within RNA polymerase
CC       III, or in stimulating catalytic functions of other subunits during
CC       initiation. Plays a key role in sensing and limiting infection by
CC       intracellular bacteria and DNA viruses. Acts as nuclear and cytosolic
CC       DNA sensor involved in innate immune response. Can sense non-self dsDNA
CC       that serves as template for transcription into dsRNA. The non-self RNA
CC       polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs
CC       (EBERs) induce type I interferon and NF- Kappa-B through the RIG-I
CC       pathway. Preferentially binds single-stranded DNA (ssDNA) in a
CC       sequence-independent manner (PubMed:21358628).
CC       {ECO:0000269|PubMed:19609254, ECO:0000269|PubMed:19631370,
CC       ECO:0000269|PubMed:21358628}.
CC   -!- SUBUNIT: Component of the RNA polymerase III (Pol III) complex
CC       consisting of 17 subunits (By similarity). RPC3/POLR3C, RPC6/POLR3F and
CC       RPC7/POLR3G form a Pol III subcomplex (PubMed:9171375,
CC       PubMed:12391170). Directly interacts with POLR3G and POLR3GL
CC       (PubMed:24107381, PubMed:21358628, PubMed:26394183). Directly interacts
CC       with POLR3F/RPC39 (PubMed:26394183). Interacts with GTF3C4
CC       (PubMed:10523658). {ECO:0000250, ECO:0000269|PubMed:10523658,
CC       ECO:0000269|PubMed:12391170, ECO:0000269|PubMed:21358628,
CC       ECO:0000269|PubMed:24107381, ECO:0000269|PubMed:26394183,
CC       ECO:0000269|PubMed:9171375}.
CC   -!- INTERACTION:
CC       Q9BUI4; Q86SG2: ANKRD23; NbExp=3; IntAct=EBI-5452779, EBI-5661893;
CC       Q9BUI4; Q13554-3: CAMK2B; NbExp=3; IntAct=EBI-5452779, EBI-11523526;
CC       Q9BUI4; Q9C0F1: CEP44; NbExp=3; IntAct=EBI-5452779, EBI-744115;
CC       Q9BUI4; Q96MT8-3: CEP63; NbExp=5; IntAct=EBI-5452779, EBI-11522539;
CC       Q9BUI4; P38432: COIL; NbExp=3; IntAct=EBI-5452779, EBI-945751;
CC       Q9BUI4; Q9NRI5-2: DISC1; NbExp=3; IntAct=EBI-5452779, EBI-11988027;
CC       Q9BUI4; Q9H0I2: ENKD1; NbExp=3; IntAct=EBI-5452779, EBI-744099;
CC       Q9BUI4; Q08379: GOLGA2; NbExp=3; IntAct=EBI-5452779, EBI-618309;
CC       Q9BUI4; Q96CS2: HAUS1; NbExp=3; IntAct=EBI-5452779, EBI-2514791;
CC       Q9BUI4; Q0VD86: INCA1; NbExp=3; IntAct=EBI-5452779, EBI-6509505;
CC       Q9BUI4; Q9H079: KATNBL1; NbExp=3; IntAct=EBI-5452779, EBI-715394;
CC       Q9BUI4; Q6ZU52: KIAA0408; NbExp=4; IntAct=EBI-5452779, EBI-739493;
CC       Q9BUI4; O95198: KLHL2; NbExp=3; IntAct=EBI-5452779, EBI-746999;
CC       Q9BUI4; P52294: KPNA1; NbExp=3; IntAct=EBI-5452779, EBI-358383;
CC       Q9BUI4; O00505: KPNA3; NbExp=3; IntAct=EBI-5452779, EBI-358297;
CC       Q9BUI4; O60684: KPNA6; NbExp=5; IntAct=EBI-5452779, EBI-359923;
CC       Q9BUI4; O95678: KRT75; NbExp=3; IntAct=EBI-5452779, EBI-2949715;
CC       Q9BUI4; Q9Y250: LZTS1; NbExp=3; IntAct=EBI-5452779, EBI-1216080;
CC       Q9BUI4; Q9NZQ3-3: NCKIPSD; NbExp=3; IntAct=EBI-5452779, EBI-10963850;
CC       Q9BUI4; P26367: PAX6; NbExp=3; IntAct=EBI-5452779, EBI-747278;
CC       Q9BUI4; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-5452779, EBI-79165;
CC       Q9BUI4; Q96PV4: PNMA5; NbExp=3; IntAct=EBI-5452779, EBI-10171633;
CC       Q9BUI4; Q9H1D9: POLR3F; NbExp=2; IntAct=EBI-5452779, EBI-710067;
CC       Q9BUI4; O15318: POLR3G; NbExp=7; IntAct=EBI-5452779, EBI-12362221;
CC       Q9BUI4; Q9BT43: POLR3GL; NbExp=7; IntAct=EBI-5452779, EBI-2855862;
CC       Q9BUI4; P78424: POU6F2; NbExp=3; IntAct=EBI-5452779, EBI-12029004;
CC       Q9BUI4; Q8NC74: RBBP8NL; NbExp=3; IntAct=EBI-5452779, EBI-11322432;
CC       Q9BUI4; Q13464: ROCK1; NbExp=3; IntAct=EBI-5452779, EBI-876651;
CC       Q9BUI4; Q9HAT0: ROPN1; NbExp=3; IntAct=EBI-5452779, EBI-1378139;
CC       Q9BUI4; P23497-2: SP100; NbExp=3; IntAct=EBI-5452779, EBI-6589365;
CC       Q9BUI4; A1L306: TNR; NbExp=3; IntAct=EBI-5452779, EBI-10182881;
CC       Q9BUI4; Q12933: TRAF2; NbExp=3; IntAct=EBI-5452779, EBI-355744;
CC       Q9BUI4; P14373: TRIM27; NbExp=6; IntAct=EBI-5452779, EBI-719493;
CC       Q9BUI4; Q04323-2: UBXN1; NbExp=3; IntAct=EBI-5452779, EBI-11530712;
CC       Q9BUI4; Q5SQQ9-2: VAX1; NbExp=3; IntAct=EBI-5452779, EBI-12227803;
CC       Q9BUI4; Q9H8Y1: VRTN; NbExp=3; IntAct=EBI-5452779, EBI-12894399;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- MISCELLANEOUS: Antibodies against POLR3C have been found in the sera of
CC       patients with systemic sclerosis (SSc).
CC   -!- SIMILARITY: Belongs to the eukaryotic RPC3/POLR3C RNA polymerase
CC       subunit family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U93867; AAB63675.1; -; mRNA.
DR   EMBL; AY091463; AAM12033.1; -; mRNA.
DR   EMBL; AJ238221; CAB41919.1; -; Genomic_DNA.
DR   EMBL; AJ238222; CAB41919.1; JOINED; Genomic_DNA.
DR   EMBL; AJ238223; CAB41919.1; JOINED; Genomic_DNA.
DR   EMBL; AJ238224; CAB41919.1; JOINED; Genomic_DNA.
DR   EMBL; AJ238225; CAB41919.1; JOINED; Genomic_DNA.
DR   EMBL; AJ238226; CAB41919.1; JOINED; Genomic_DNA.
DR   EMBL; AJ238227; CAB41919.1; JOINED; Genomic_DNA.
DR   EMBL; AJ238228; CAB41919.1; JOINED; Genomic_DNA.
DR   EMBL; AJ238229; CAB41919.1; JOINED; Genomic_DNA.
DR   EMBL; AJ238230; CAB41919.1; JOINED; Genomic_DNA.
DR   EMBL; AJ238231; CAB41919.1; JOINED; Genomic_DNA.
DR   EMBL; AJ238232; CAB41919.1; JOINED; Genomic_DNA.
DR   EMBL; AJ238233; CAB41919.1; JOINED; Genomic_DNA.
DR   EMBL; AJ238234; CAB41919.1; JOINED; Genomic_DNA.
DR   EMBL; BC002586; AAH02586.1; -; mRNA.
DR   CCDS; CCDS72864.1; -.
DR   RefSeq; NP_001290385.1; NM_001303456.1.
DR   RefSeq; NP_006459.3; NM_006468.7.
DR   PDB; 2XUB; X-ray; 2.80 A; A=1-534.
DR   PDB; 2XV4; X-ray; 2.95 A; S=1-534.
DR   PDB; 5AFQ; X-ray; 7.00 A; A/B=1-534.
DR   PDB; 7A6H; EM; 3.30 A; O=1-534.
DR   PDB; 7AE1; EM; 2.80 A; O=1-534.
DR   PDB; 7AE3; EM; 3.10 A; O=1-534.
DR   PDB; 7AEA; EM; 3.40 A; O=1-534.
DR   PDB; 7AST; EM; 4.00 A; X=1-534.
DR   PDB; 7D58; EM; 2.90 A; O=1-534.
DR   PDB; 7D59; EM; 3.10 A; O=1-534.
DR   PDB; 7DN3; EM; 3.50 A; O=1-534.
DR   PDB; 7DU2; EM; 3.35 A; O=1-534.
DR   PDB; 7FJI; EM; 3.60 A; O=1-534.
DR   PDB; 7FJJ; EM; 3.60 A; O=1-534.
DR   PDBsum; 2XUB; -.
DR   PDBsum; 2XV4; -.
DR   PDBsum; 5AFQ; -.
DR   PDBsum; 7A6H; -.
DR   PDBsum; 7AE1; -.
DR   PDBsum; 7AE3; -.
DR   PDBsum; 7AEA; -.
DR   PDBsum; 7AST; -.
DR   PDBsum; 7D58; -.
DR   PDBsum; 7D59; -.
DR   PDBsum; 7DN3; -.
DR   PDBsum; 7DU2; -.
DR   PDBsum; 7FJI; -.
DR   PDBsum; 7FJJ; -.
DR   AlphaFoldDB; Q9BUI4; -.
DR   SMR; Q9BUI4; -.
DR   BioGRID; 115868; 89.
DR   DIP; DIP-59078N; -.
DR   IntAct; Q9BUI4; 49.
DR   STRING; 9606.ENSP00000334564; -.
DR   iPTMnet; Q9BUI4; -.
DR   MetOSite; Q9BUI4; -.
DR   PhosphoSitePlus; Q9BUI4; -.
DR   SwissPalm; Q9BUI4; -.
DR   BioMuta; POLR3C; -.
DR   DMDM; 60393871; -.
DR   EPD; Q9BUI4; -.
DR   jPOST; Q9BUI4; -.
DR   MassIVE; Q9BUI4; -.
DR   MaxQB; Q9BUI4; -.
DR   PaxDb; Q9BUI4; -.
DR   PeptideAtlas; Q9BUI4; -.
DR   PRIDE; Q9BUI4; -.
DR   ProteomicsDB; 79088; -.
DR   Antibodypedia; 33966; 256 antibodies from 24 providers.
DR   DNASU; 10623; -.
DR   Ensembl; ENST00000334163.4; ENSP00000334564.3; ENSG00000186141.9.
DR   GeneID; 10623; -.
DR   KEGG; hsa:10623; -.
DR   MANE-Select; ENST00000334163.4; ENSP00000334564.3; NM_006468.8; NP_006459.3.
DR   UCSC; uc001eoh.3; human.
DR   CTD; 10623; -.
DR   DisGeNET; 10623; -.
DR   GeneCards; POLR3C; -.
DR   HGNC; HGNC:30076; POLR3C.
DR   HPA; ENSG00000186141; Low tissue specificity.
DR   MIM; 617454; gene.
DR   neXtProt; NX_Q9BUI4; -.
DR   OpenTargets; ENSG00000186141; -.
DR   PharmGKB; PA134870963; -.
DR   VEuPathDB; HostDB:ENSG00000186141; -.
DR   eggNOG; KOG2587; Eukaryota.
DR   GeneTree; ENSGT00390000002799; -.
DR   HOGENOM; CLU_023294_1_1_1; -.
DR   InParanoid; Q9BUI4; -.
DR   OMA; FETNECD; -.
DR   OrthoDB; 809282at2759; -.
DR   PhylomeDB; Q9BUI4; -.
DR   TreeFam; TF103048; -.
DR   PathwayCommons; Q9BUI4; -.
DR   Reactome; R-HSA-1834949; Cytosolic sensors of pathogen-associated DNA.
DR   Reactome; R-HSA-73780; RNA Polymerase III Chain Elongation.
DR   Reactome; R-HSA-73980; RNA Polymerase III Transcription Termination.
DR   Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR   Reactome; R-HSA-76061; RNA Polymerase III Transcription Initiation From Type 1 Promoter.
DR   Reactome; R-HSA-76066; RNA Polymerase III Transcription Initiation From Type 2 Promoter.
DR   Reactome; R-HSA-76071; RNA Polymerase III Transcription Initiation From Type 3 Promoter.
DR   SignaLink; Q9BUI4; -.
DR   SIGNOR; Q9BUI4; -.
DR   BioGRID-ORCS; 10623; 716 hits in 1093 CRISPR screens.
DR   ChiTaRS; POLR3C; human.
DR   EvolutionaryTrace; Q9BUI4; -.
DR   GeneWiki; POLR3C; -.
DR   GenomeRNAi; 10623; -.
DR   Pharos; Q9BUI4; Tbio.
DR   PRO; PR:Q9BUI4; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9BUI4; protein.
DR   Bgee; ENSG00000186141; Expressed in calcaneal tendon and 177 other tissues.
DR   ExpressionAtlas; Q9BUI4; baseline and differential.
DR   Genevisible; Q9BUI4; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005666; C:RNA polymerase III complex; IDA:MGI.
DR   GO; GO:0003899; F:DNA-directed 5'-3' RNA polymerase activity; TAS:ProtInc.
DR   GO; GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0045089; P:positive regulation of innate immune response; IMP:UniProtKB.
DR   GO; GO:0032728; P:positive regulation of interferon-beta production; IMP:UniProtKB.
DR   GO; GO:0006359; P:regulation of transcription by RNA polymerase III; TAS:ProtInc.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   Gene3D; 1.10.10.10; -; 4.
DR   InterPro; IPR013197; RNA_pol_III_RPC82-rel_HTH.
DR   InterPro; IPR008806; RNA_pol_III_Rpc82_C.
DR   InterPro; IPR039748; RPC3.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   PANTHER; PTHR12949; PTHR12949; 1.
DR   Pfam; PF08221; HTH_9; 1.
DR   Pfam; PF05645; RNA_pol_Rpc82; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antiviral defense; DNA-binding; DNA-directed RNA polymerase;
KW   Immunity; Innate immunity; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription.
FT   CHAIN           1..534
FT                   /note="DNA-directed RNA polymerase III subunit RPC3"
FT                   /id="PRO_0000073963"
FT   REGION          161..181
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          197..228
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        199..226
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         194
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   VARIANT         243
FT                   /note="H -> R (in dbSNP:rs1044697)"
FT                   /evidence="ECO:0000269|PubMed:9171375"
FT                   /id="VAR_019083"
FT   MUTAGEN         51..52
FT                   /note="KK->EE: Strongly decreased ssDNA-binding. No effect
FT                   on interaction with POLR3F, POLR3G, nor with POLR3GL."
FT                   /evidence="ECO:0000269|PubMed:21358628"
FT   MUTAGEN         312
FT                   /note="L->K: Loss of interaction with POLR3G and POLR3GL.
FT                   No effect on interaction with POLR3F."
FT                   /evidence="ECO:0000269|PubMed:21358628"
FT   MUTAGEN         357
FT                   /note="R->E: Strongly decreased ssDNA-binding. No effect on
FT                   interaction with POLR3F, POLR3G, nor with POLR3GL."
FT                   /evidence="ECO:0000269|PubMed:21358628"
FT   MUTAGEN         364..367
FT                   /note="RIFR->EIFE: Strongly decreased ssDNA-binding. No
FT                   effect on interaction with POLR3F, POLR3G, nor with
FT                   POLR3GL."
FT                   /evidence="ECO:0000269|PubMed:21358628"
FT   MUTAGEN         389
FT                   /note="K->E: Strongly decreased ssDNA-binding. No effect on
FT                   interaction with POLR3F, POLR3G, nor with POLR3GL."
FT                   /evidence="ECO:0000269|PubMed:21358628"
FT   MUTAGEN         445..449
FT                   /note="NLIER->ALIEE: Strongly decreased ssDNA-binding. No
FT                   effect on interaction with POLR3F, POLR3G, nor with
FT                   POLR3GL."
FT                   /evidence="ECO:0000269|PubMed:21358628"
FT   MUTAGEN         466..470
FT                   /note="RVEAI->EVEAF: Mild decrease in ssDNA-binding. No
FT                   effect on interaction with POLR3F, POLR3G, nor with
FT                   POLR3GL."
FT                   /evidence="ECO:0000269|PubMed:21358628"
FT   CONFLICT        85..86
FT                   /note="ML -> IV (in Ref. 1; AAB63675)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        119..120
FT                   /note="SA -> CT (in Ref. 1; AAB63675)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        216..237
FT                   /note="KRPKYTTDNKEPIPDDGIYWQA -> RDQNILQITRXPFQMMGFIGRP (in
FT                   Ref. 1; AAB63675)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        289
FT                   /note="S -> F (in Ref. 1; AAB63675)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        343
FT                   /note="A -> R (in Ref. 1; AAB63675)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        366
FT                   /note="F -> C (in Ref. 1; AAB63675)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        387..389
FT                   /note="PAK -> LQ (in Ref. 1; AAB63675)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        401
FT                   /note="E -> G (in Ref. 1; AAB63675)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        436..437
FT                   /note="LH -> FD (in Ref. 1; AAB63675)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        517
FT                   /note="D -> E (in Ref. 3; CAB41919)"
FT                   /evidence="ECO:0000305"
FT   HELIX           3..31
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   STRAND          33..35
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   HELIX           36..43
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   HELIX           47..59
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   STRAND          62..68
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   TURN            69..71
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   STRAND          72..77
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   HELIX           79..83
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   HELIX           84..87
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   HELIX           88..113
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   STRAND          114..116
FT                   /evidence="ECO:0007829|PDB:7D58"
FT   HELIX           118..131
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   STRAND          133..136
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   HELIX           141..153
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   STRAND          156..159
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   TURN            166..168
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   STRAND          171..175
FT                   /evidence="ECO:0007829|PDB:7DU2"
FT   STRAND          184..186
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   TURN            229..232
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   STRAND          234..237
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   HELIX           239..258
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   HELIX           261..272
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   TURN            273..277
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   HELIX           290..295
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   HELIX           305..316
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   STRAND          317..319
FT                   /evidence="ECO:0007829|PDB:7DU2"
FT   STRAND          323..325
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   STRAND          329..331
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   STRAND          333..337
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   HELIX           338..358
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   HELIX           360..371
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   STRAND          372..375
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   HELIX           377..384
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   HELIX           388..400
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   STRAND          403..406
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   STRAND          409..412
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   HELIX           417..419
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   STRAND          421..425
FT                   /evidence="ECO:0007829|PDB:7D59"
FT   HELIX           428..456
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   HELIX           458..472
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   STRAND          473..476
FT                   /evidence="ECO:0007829|PDB:7AE3"
FT   HELIX           481..483
FT                   /evidence="ECO:0007829|PDB:7AE1"
FT   HELIX           485..488
FT                   /evidence="ECO:0007829|PDB:2XUB"
FT   HELIX           493..529
FT                   /evidence="ECO:0007829|PDB:2XUB"
SQ   SEQUENCE   534 AA;  60612 MW;  0E4CFEE295EE1A55 CRC64;
     MTQAEIKLCS LLLQEHFGEI VEKIGVHLIR TGSQPLRVIA HDTGTSLDQV KKALCVLVQH
     NLVSYQVHKR GVVEYEAQCS RVLRMLRYPR YIYTTKTLYS DTGELIVEEL LLNGKLTMSA
     VVKKVADRLT ETMEDGKTMD YAEVSNTFVR LADTHFVQRC PSVPTTENSD PGPPPPAPTL
     VINEKDMYLV PKLSLIGKGK RRRSSDEDAA GEPKAKRPKY TTDNKEPIPD DGIYWQANLD
     RFHQHFRDQA IVSAVANRMD QTSSEIVRTM LRMSEITTSS SAPFTQPLSS NEIFRSLPVG
     YNISKQVLDQ YLTLLADDPL EFVGKSGDSG GGMYVINLHK ALASLATATL ESVVQERFGS
     RCARIFRLVL QKKHIEQKQV EDFAMIPAKE AKDMLYKMLS ENFMSLQEIP KTPDHAPSRT
     FYLYTVNILS AARMLLHRCY KSIANLIERR QFETKENKRL LEKSQRVEAI IASMQATGAE
     EAQLQEIEEM ITAPERQQLE TLKRNVNKLD ASEIQVDETI FLLESYIECT MKRQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024